体内与离体照射用于三色荧光原位杂交个体放射敏感性检测的可靠性比较
该研究对274例直肠癌和43例肺癌放疗患者的外周血分别进行2 Gy离体与在体照射,用三色荧光原位杂交检测1、2、4号染色体断裂。结果显示离体与在体染色体畸变仅弱相关,且在体照射因多种因素影响难以估算个体放射敏感性,作者建议优先采用离体检测。
要点
- 离体与在体照射后染色体断裂/中期细胞(B/M)仅呈弱相关。
- 肺癌队列沉积能量显著更小但B/M值与直肠癌队列相似。
- 校正个体沉积能量差异后相关性仅略有改善。
核心结论
- 由于多种因素影响染色体畸变诱导,通过在体照射估算个体放射敏感性似乎不可行,应优先选择离体估算个体放射敏感性。
研究设计与样本
- 研究纳入274例接受放疗的直肠癌患者和43例肺癌患者的外周血样本。
- 样本分别接受2 Gy离体与在体电离辐射,采用三色荧光原位杂交染色1、2、4号染色体。
- 以每中期细胞断裂数(B/M)分析染色体畸变,并计算每例患者每次照射的沉积能量。
主要发现
- 离体与在体染色体畸变之间仅发现弱相关。
- 肺癌队列在放疗期间接受的沉积能量显著更小,但其B/M值与直肠癌队列相似。
- 考虑个体沉积能量差异后,离体与在体结果的相关性仅略有改善。
临床怎么用
- 个体放射敏感性检测宜采用离体照射方案,不宜用在体照射替代。
- 解读在体照射下的染色体畸变结果时需考虑沉积能量等个体差异因素。
局限性
- 原文未报告具体相关性数值、P值及沉积能量的具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Individual radiosensitivity is influencing the outcome of radiation therapy. A general ex vivo testing is very work-intensive. It is of interest to see if a significant prediction concerning the sensitivity can be made by in vivo irradiation during radiation treatment. METHODS: Blood samples of 274 patients with rectal cancer and 43 lung cancer patients receiving radiotherapy were examined after 2 Gy ex vivo and in vivo ionizing radiation. Chromosomes # 1, 2 and 4 were stained by the 3-color-fluorescence in situ hybridization. Chromosomal aberrations were analyzed as breaks per metaphase (B/M). The deposited energy per session was calculated for each patient. RESULTS: Weak correlation could be found between the chromosomal aberrations ex and in vivo. Though receiving significantly smaller deposited energy during radiation therapy (RT) the lung cancer cohort displayed B/M values similar to the rectal cancer cohort. Considering the individual deposit energy differences improved slightly the correlation. CONCLUSIONS: As various factors influence the induction of chromosomal aberrations it seems not feasible to estimate individual radiosensitivity via in vivo irradiation. An ex vivo estimation of individual radiosensitivity should be preferred.
引用
- Mayo T, Haderlein M, Schuster B, et al. Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization? Radiat Oncol. 2019. PMID: 31892333. doi:10.1186/s13014-019-1444-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。